Where can I buy the targeted drug sotoraxib (AMG510)?

Sotoracib (AMG510) is a promising KRAS G12C inhibitor that increases available treatment options for patients with KRAS G12C mutation-positive non-small cell lung cancer who have previously received platinum-based chemotherapy and/or immunotherapy. The original drug of Sotolaxib has not yet been launched in China, and domestic patients cannot yet purchase this drug. Currently, the original drug of Sotolasibu is sold in Hong Kong, China, with a price of about RMB 80,000. The price of the European original research version sold overseas is more than 40,000 yuan. There are also generic drugs of sotorasibu on the market. The ingredients of the drug are similar to the original ones, and the price is relatively cheap. For example, the price of each box of Laos Lucius Pharmaceutical Factory and Daxiong Pharmaceutical is more than 2,000 yuan. For more information on overseas drug prices and related information, please consult Yaode Medical Consultant.